Related Experiment Videos
Correction: Marked variability in bioactivity between commercially available bovine colostrum for human use;
Plos One
|October 6, 2020
Summary
This study corrects a previously published article DOI. The correction ensures accurate citation and retrieval of scientific literature for researchers.
Area of Science:
- Scientific Publishing
- Bibliometrics
- Scholarly Communication
Context:
- Accurate citation is crucial for scientific integrity.
- Digital Object Identifiers (DOIs) are essential for locating research.
- Errors in DOIs can hinder research accessibility.
Purpose:
- To correct an erroneous DOI in a published article.
- To ensure the correct article is linked and retrievable.
- To maintain the integrity of the scientific record.
Summary:
- A correction has been issued for the article with DOI 10.1371/journal.pone.0234719.
- This correction rectifies a previous error in the article's DOI.
- The updated DOI ensures proper referencing and access to the research.
Impact:
- Improves the accuracy of scientific literature databases.
- Facilitates correct citation and retrieval of the research.
- Upholds scholarly communication standards.
Related Concept Videos
Bioavailability: Influencing Factors
168
Bioavailability refers to the extent and rate at which a drug reaches systemic circulation in its active form. Extent refers to the amount of the drug that makes it into circulation, while rate is the speed at which it enters circulation. It is influenced by several factors critical for optimizing drug formulations, dosing regimens, and therapeutic outcomes.Physicochemical properties of drugs and formulationsThe solubility, stability, and dissolution rate of a drug significantly impact its...
168
Bioavailability Study Design: Healthy Subjects Versus Patients
61
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
61
Bioequivalence studies: Biowaivers
78
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
78
Bioequivalence Data: Statistical Interpretation
72
Body:The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
72
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
75
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
75
Bioequivalence: Overview
1.4K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.4K